LFTD Partners Sells Kenosha Facility for $1.5M, Plans to Repay Mortgage
LIFD sits 75% above its 52-week low of $0.113 on light trading volume (0.1× avg).
Summary
LFTD Partners agreed to sell its Kenosha, Wisconsin facility for $1.5 million, using proceeds to repay an $852,755 mortgage and consolidate operations. The sale follows a period of financial strain, including a widened net loss and workforce restructuring.
Key Events · M&A and Partnerships · LIFD
-
Facility Sale Agreement
Lifted Liquids, a subsidiary, agreed to sell its 11,238 sq ft Kenosha facility to Ad Real Estate Group LLC for $1.5 million, with $150,000 in earnest money.
-
Mortgage Repayment
Net proceeds will repay the outstanding $852,755 mortgage on the property, reducing debt and interest costs.
-
Operational Consolidation
Post-sale, the company plans to consolidate operations into other leased facilities in Kenosha, potentially lowering overhead.
-
Closing Timeline
Closing is scheduled for September 16, 2026, subject to zoning, inspections, and other customary contingencies.
Analysis · LIFD · Life Sciences
LFTD Partners is selling its main operating facility for $1.5 million, a significant transaction for a company with a market cap under $3 million. The sale provides critical cash to repay the $852,755 mortgage and consolidate operations, addressing liquidity pressures highlighted by recent losses and workforce reductions. The deal is subject to customary closing conditions and is expected to close by mid-September 2026.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 30% of the 1759 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.34%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LIFD was trading at $0.20 on OTC in the Life Sciences sector, with a market capitalization of approximately $2.9M. The 52-week trading range was $0.11 to $1.10. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.